# First Bancorp: financial statements, quarterly

FBP · NYSE · CIK 1057706 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fbp.md) · [Financials](/companies/fbp/financials.md) · [Filings](/companies/fbp/filings.md) · [Insiders](/companies/fbp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fbp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [230](/filings/0001057706-24-000014.md) | [230 d](/filings/0001057706-26-000007.md) | [231](/filings/0001057706-25-000005.md) | [232](/filings/0001057706-25-000007.md) | [235](/filings/0001057706-25-000012.md) | [241 d](/filings/0001057706-26-000007.md) | [248](/filings/0001057706-26-000012.md) | [247](/filings/0001057706-26-000023.md) | [249](/filings/0001057706-25-000012.md) | [257 d](/filings/0001057706-26-000007.md) | [259](/filings/0001057706-26-000012.md) | [265](/filings/0001057706-26-000023.md) |
| Interest expense | $m | [63.7](/filings/0001057706-23-000008.md) | [68.8 d](/filings/0001057706-24-000004.md) | [72.0](/filings/0001057706-24-000007.md) | [72.6](/filings/0001057706-24-000009.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [27.0](/filings/0001057706-24-000014.md) | [5.4 d](/filings/0001057706-26-000007.md) | [24.0](/filings/0001057706-25-000005.md) | [25.5](/filings/0001057706-25-000007.md) | [22.7](/filings/0001057706-25-000012.md) | [20.3 d](/filings/0001057706-26-000007.md) | [23.2](/filings/0001057706-26-000012.md) | [22.7](/filings/0001057706-26-000023.md) | [5.7](/filings/0001057706-25-000012.md) | [20.2 d](/filings/0001057706-26-000007.md) | [25.5](/filings/0001057706-26-000012.md) | [24.1](/filings/0001057706-26-000023.md) |
| Net income | $m | [82.0](/filings/0001057706-24-000014.md) | [79.5 d](/filings/0001057706-26-000007.md) | [73.5](/filings/0001057706-25-000005.md) | [75.8](/filings/0001057706-25-000007.md) | [73.7](/filings/0001057706-25-000012.md) | [75.7 d](/filings/0001057706-26-000007.md) | [77.1](/filings/0001057706-26-000012.md) | [80.2](/filings/0001057706-26-000023.md) | [101](/filings/0001057706-25-000012.md) | [87.1 d](/filings/0001057706-26-000007.md) | [88.8](/filings/0001057706-26-000012.md) | [96.2](/filings/0001057706-26-000023.md) |
| Diluted EPS | $ per share | [0.46](/filings/0001057706-24-000014.md) | not reported | [0.44](/filings/0001057706-25-000005.md) | [0.46](/filings/0001057706-25-000007.md) | [0.45](/filings/0001057706-25-000012.md) | not reported | [0.47](/filings/0001057706-26-000012.md) | [0.50](/filings/0001057706-26-000023.md) | [0.63](/filings/0001057706-25-000012.md) | not reported | [0.57](/filings/0001057706-26-000012.md) | [0.62](/filings/0001057706-26-000023.md) |
| Basic EPS | $ per share | [0.47](/filings/0001057706-24-000014.md) | not reported | [0.44](/filings/0001057706-25-000005.md) | [0.46](/filings/0001057706-25-000007.md) | [0.45](/filings/0001057706-25-000012.md) | not reported | [0.47](/filings/0001057706-26-000012.md) | [0.50](/filings/0001057706-26-000023.md) | [0.63](/filings/0001057706-25-000012.md) | not reported | [0.57](/filings/0001057706-26-000012.md) | [0.63](/filings/0001057706-26-000023.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [18.6](/filings/0001057706-23-000008.md) | [18.9](/filings/0001057706-25-000002.md) | [18.9](/filings/0001057706-24-000007.md) | [18.9](/filings/0001057706-24-000009.md) | [18.9](/filings/0001057706-24-000014.md) | [19.3](/filings/0001057706-26-000007.md) | [19.1](/filings/0001057706-25-000005.md) | [18.9](/filings/0001057706-25-000007.md) | [19.3](/filings/0001057706-25-000012.md) | [19.1](/filings/0001057706-26-000023.md) | [19.1](/filings/0001057706-26-000012.md) | [19.2](/filings/0001057706-26-000023.md) |
| Total liabilities | $bn | [17.3](/filings/0001057706-23-000008.md) | [17.4](/filings/0001057706-25-000002.md) | [17.4](/filings/0001057706-24-000007.md) | [17.4](/filings/0001057706-24-000009.md) | [17.2](/filings/0001057706-24-000014.md) | [17.6](/filings/0001057706-26-000007.md) | [17.3](/filings/0001057706-25-000005.md) | [17.1](/filings/0001057706-25-000007.md) | [17.4](/filings/0001057706-25-000012.md) | [17.2](/filings/0001057706-26-000023.md) | [17.1](/filings/0001057706-26-000012.md) | [17.3](/filings/0001057706-26-000023.md) |
| Long-term debt | $bn | not reported | [0.7](/filings/0001057706-25-000002.md) | not reported | not reported | not reported | [0.6](/filings/0001057706-26-000007.md) | [0.3](/filings/0001057706-25-000005.md) | [0.3](/filings/0001057706-25-000007.md) | [0.3](/filings/0001057706-25-000012.md) | [0.3](/filings/0001057706-26-000023.md) | [0.2](/filings/0001057706-26-000012.md) | [0.2](/filings/0001057706-26-000023.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001057706-26-000012.md) | [0.1](/filings/0001057706-26-000012.md) | not reported |
| Shareholders' equity | $bn | [1.3](/filings/0001057706-24-000014.md) | [1.5](/filings/0001057706-26-000007.md) | [1.5](/filings/0001057706-25-000005.md) | [1.5](/filings/0001057706-25-000007.md) | [1.7](/filings/0001057706-25-000012.md) | [1.7](/filings/0001057706-26-000007.md) | [1.8](/filings/0001057706-26-000012.md) | [1.8](/filings/0001057706-26-000023.md) | [1.9](/filings/0001057706-25-000012.md) | [2.0](/filings/0001057706-26-000023.md) | [2.0](/filings/0001057706-26-000012.md) | [2.0](/filings/0001057706-26-000023.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [117 d](/filings/0001057706-24-000014.md) | [79.2 d](/filings/0001057706-26-000007.md) | [118](/filings/0001057706-25-000005.md) | [71.1 d](/filings/0001057706-25-000007.md) | [118 d](/filings/0001057706-25-000012.md) | [96.8 d](/filings/0001057706-26-000007.md) | [108](/filings/0001057706-26-000012.md) | [95.4 d](/filings/0001057706-26-000023.md) | [138 d](/filings/0001057706-25-000012.md) | [107 d](/filings/0001057706-26-000007.md) | [121](/filings/0001057706-26-000012.md) | [92.2 d](/filings/0001057706-26-000023.md) |
| Capital expenditure | $m | [3.7 d](/filings/0001057706-24-000014.md) | [2.7 d](/filings/0001057706-26-000007.md) | [4.1](/filings/0001057706-25-000005.md) | [1.7 d](/filings/0001057706-25-000007.md) | [2.5 d](/filings/0001057706-25-000012.md) | [1.6 d](/filings/0001057706-26-000007.md) | [1.5](/filings/0001057706-26-000012.md) | [2.6 d](/filings/0001057706-26-000023.md) | [2.9 d](/filings/0001057706-25-000012.md) | [4.1 d](/filings/0001057706-26-000007.md) | [5.2](/filings/0001057706-26-000012.md) | [5.0 d](/filings/0001057706-26-000023.md) |
| Dividends paid | $m | [24.7 d](/filings/0001057706-24-000014.md) | [23.8 d](/filings/0001057706-26-000007.md) | [26.6](/filings/0001057706-25-000005.md) | [26.8 d](/filings/0001057706-25-000007.md) | [26.0 d](/filings/0001057706-25-000012.md) | [26.1 d](/filings/0001057706-26-000007.md) | [29.3](/filings/0001057706-26-000012.md) | [29.7 d](/filings/0001057706-26-000023.md) | [28.5 d](/filings/0001057706-25-000012.md) | [28.0 d](/filings/0001057706-26-000007.md) | [32.1](/filings/0001057706-26-000012.md) | [31.0 d](/filings/0001057706-26-000023.md) |
| Share repurchases | $m | [73.7 d](/filings/0001057706-24-000014.md) | [76.3 d](/filings/0001057706-26-000007.md) | [52.4](/filings/0001057706-25-000005.md) | [49.2 d](/filings/0001057706-25-000007.md) | [0.8 d](/filings/0001057706-25-000012.md) | [0.0 d](/filings/0001057706-26-000007.md) | [24.9](/filings/0001057706-26-000012.md) | [28.7 d](/filings/0001057706-26-000023.md) | [50.1 d](/filings/0001057706-25-000012.md) | [50.0 d](/filings/0001057706-26-000007.md) | [54.6](/filings/0001057706-26-000012.md) | [50.3 d](/filings/0001057706-26-000023.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [188](/filings/0001057706-23-000008.md) | [181](/filings/0001057706-24-000007.md) | [179](/filings/0001057706-24-000009.md) | [177](/filings/0001057706-24-000014.md) | [168](/filings/0001057706-25-000005.md) | [166](/filings/0001057706-25-000007.md) | [164](/filings/0001057706-25-000012.md) | [164](/filings/0001057706-26-000012.md) | [162](/filings/0001057706-26-000023.md) | [160](/filings/0001057706-25-000012.md) | [156](/filings/0001057706-26-000012.md) | [154](/filings/0001057706-26-000023.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 152,668,268 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001057706-26-000023.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.